Active Ingredients: Norfloxacin
+ free Noroxin pill.
Medical uses The initial approval by the U. It licensed use in acute and chronic complicated kidney infections has been withdrawn as a result.
Several reports have linked BV with sexual behaviour, a recent change of sexual partner, as well as multiple partners.
The invention will now be further described and illustrated by reference to the following examples, which have been carefully selected in order to encompass the invention. Accordingly, they should not be construed as limiting the invention in any way.
The novel oligomers of lactic acids does not encompass a tetramer of lactic acid manufactured as described in the following: To a solution of lactic acid tetramer tert-butyl ester 0. However, in relation to use of oligomers of lactic acid it is envisaged that small structural variations of the oligomers do not affect their ability to release lactic acid.
Group B Streptococcus, fungi, viruses, or parasites. Intuitively, if the weight average molecular weight is w, and you pick a random monomer, then the polymer it belongs to will have a weight of w on average.
The weight average molecular weight can be determined by e. The number average molecular weight is the common, mean, average of the molecular weights of the individual polymers. The number average molecular weight of a polymer can be determined by e.
As appears from the description and the examples herein, oligomeric products are normally obtained by use of the synthesis method and the polydispersity index is used as a measure for how broad or narrow the molecular weight distribution is.
As explained herein, it is normally an advantage to have oligomers of different molecular weights in the product as it e. In this manner it is possible to design an oligomeric product with a desired release profile.
Oligomers of Lactic Acid In one embodiment relating to oligomers of lactic acid per se, the invention comprises one or more oligomers of lactic acid with formula I, wherein n is an integer as defined herein in connection with formula I.
The novel oligomers of lactic acids in pure form does not encompass a tetramer of lactic acid manufactured as described in the following: To a solution of lactic acid tetramer tert-butyl ester 0. Preferably the tablets should be taken in the morning and evening.
If you only take a single daily dose, always take this at the same time of day.